BSE - Delayed Quote
INR
Neuland Laboratories Limited (NEULANDLAB.BO)
20,323.05
+446.25
(+2.25%)
At close: 3:29:59 PM GMT+5:30
Loading chart for NEULANDLAB.BO
- Previous Close
19,876.80 - Open
19,873.30 - Bid 20,306.20 x --
- Ask 20,325.90 x --
- Day's Range
19,658.50 - 20,990.00 - 52 Week Range
11,500.00 - 24,235.05 - Volume
3,066 - Avg. Volume
3,237 - Market Cap (intraday)
260.742B - Beta (5Y Monthly) 0.34
- PE Ratio (TTM)
57.62 - EPS (TTM)
352.71 - Earnings Date (est.) --
- Forward Dividend & Yield 34.00 (0.17%)
- 1y Target Est
24,675.00 - Moby Rating Neutral
Recent News
View MorePerformance Overview
Trailing total returns as of 11/9/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
NEULANDLAB.BO
34.04%
S&P BSE SENSEX (^BSESN)
4.83%
1-Year Return
NEULANDLAB.BO
14.25%
S&P BSE SENSEX (^BSESN)
2.54%
3-Year Return
NEULANDLAB.BO
288.02%
S&P BSE SENSEX (^BSESN)
25.10%
5-Year Return
NEULANDLAB.BO
1,142.90%
S&P BSE SENSEX (^BSESN)
34.21%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
19.61%
-
Return on Assets (ttm)
13.61%
-
Return on Equity (ttm)
24.80%
-
Revenue (ttm)
23.07B
-
Net Income Avi to Common (ttm)
4.53B
-
Diluted EPS (ttm)
352.71
Balance Sheet and Cash Flow
-
Total Cash (mrq)
4.5B
-
Total Debt/Equity (mrq)
16.87%
-
Levered Free Cash Flow (ttm)
1.42B
